Interleukin-2 in Metastatic Kidney Cancer
NCT01702909
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
7
Enrollment
OTHER
Sponsor class
Stopped
PI Decision
Conditions
Renal Cell Cancer Metastatic
Kidney Cancer Metastatic
Interventions
DRUG:
Interleukin-2
Sponsor
Western Regional Medical Center